Signs and symptoms of fast-rising 'overlooked killer' fungal infection
Dr. David Perlin, one of the world's top experts on fungi, spoke exclusively to the Record about a new variant of the ...
Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea
For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...
Basilea Pharmaceutica AG: Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
JD Supra11d
Drugs and Biologics at FDA: Reflections on 2024 Activity Shed Light on the Road Ahead
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...